As of 2026-03-16, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -1.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is 107.35 mil USD. DTIL's TTM EBITDA according to its financial statements is -81.56 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 15.5x | 14.4x |
| Forward P/E multiples | 19.8x - 26.4x | 21.9x |
| Fair Price | (46.24) - 3.68 | (23.54) |
| Upside | -915.6% - -35.1% | -515.2% |
| Date | EV/EBITDA |
| 2026-03-13 | -1.32 |
| 2026-03-12 | -1.32 |
| 2026-03-11 | -1.14 |
| 2026-03-10 | -1.23 |
| 2026-03-09 | -1.05 |
| 2026-03-06 | -1.02 |
| 2026-03-05 | -1.00 |
| 2026-03-04 | -1.06 |
| 2026-03-03 | -0.95 |
| 2026-03-02 | -0.94 |
| 2026-02-27 | -0.90 |
| 2026-02-26 | -0.84 |
| 2026-02-25 | -0.88 |
| 2026-02-24 | -0.85 |
| 2026-02-23 | -0.83 |
| 2026-02-20 | -0.79 |
| 2026-02-19 | -0.82 |
| 2026-02-18 | -0.81 |
| 2026-02-17 | -0.84 |
| 2026-02-13 | -0.82 |
| 2026-02-12 | -0.84 |
| 2026-02-11 | -0.87 |
| 2026-02-10 | -0.78 |
| 2026-02-09 | -0.79 |
| 2026-02-06 | -0.79 |
| 2026-02-05 | -0.73 |
| 2026-02-04 | -0.80 |
| 2026-02-03 | -0.81 |
| 2026-02-02 | -0.84 |
| 2026-01-30 | -0.84 |
| 2026-01-29 | -0.84 |
| 2026-01-28 | -0.84 |
| 2026-01-27 | -0.88 |
| 2026-01-26 | -0.86 |
| 2026-01-23 | -0.90 |
| 2026-01-22 | -0.92 |
| 2026-01-21 | -0.85 |
| 2026-01-20 | -0.90 |
| 2026-01-16 | -0.86 |
| 2026-01-15 | -0.82 |
| 2026-01-14 | -0.88 |
| 2026-01-13 | -0.88 |
| 2026-01-12 | -0.86 |
| 2026-01-09 | -0.82 |
| 2026-01-08 | -0.86 |
| 2026-01-07 | -0.95 |
| 2026-01-06 | -0.91 |
| 2026-01-05 | -0.87 |
| 2026-01-02 | -0.88 |
| 2025-12-31 | -0.89 |